Shanghai Fosun Pharmaceutical Group Co Ltd (600196.SS)
23 Aug 2019
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|47||2016||Chairman of the Board, Executive Director|
|49||2016||Co-Chairman of the Board|
|50||2016||President, Chief Executive Officer, Executive Director|
|48||2016||Chief Financial Officer, Senior Vice President, Chief Accounting Officer|
|44||Senior Vice President|
- China's United Family Healthcare clinches $1.4 billion deal to list in New York
- China's United Family Healthcare clinches $1.4 bln deal to list in New York
- REFILE-BRIEF-Shanghai Fosun Pharmaceutical's Units Plan Project, Sign Licence Agreement With UK Firm
- REFILE-BRIEF-Shanghai Fosun Pharmaceutical's 2018 Net Profit Down 13.3 Percent Y/Y